Related Experiment Video
Updated: Aug 19, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
Sterol composition of Pneumocystis jirovecii with blocked 14alpha-demethylase activity
José-Luis Giner1, Hui Zhao, Zunika Amit
1Department of Chemistry, State University of New York-ESF, Syracuse, NY 13210, USA. jlginer@syr.edu
Abstract:
Several drugs that interact with membrane sterols or inhibit their syntheses are effective in clearing a number of fungal infections. The AIDS-associated lung infection caused by Pneumocystis jirovecii is not cleared by many of these therapies. Pneumocystis normally synthesizes distinct C28 and C29 24-alkylsterols, but ergosterol, the major fungal sterol, is not among them. Two distinct sterol compositional phenotypes were previously observed in P. jirovecii. One was characterized by delta7 C28 and C29 24-alkylsterols with only low proportions of higher molecular mass components. In contrast, the other type was dominated by high C31 and C32 24-alkylsterols, especially pneumocysterol. In the present study, 28 molecular species were elucidated by nuclear magnetic resonance analysis of a human lung specimen containing P. jirovecii representing the latter sterol profile phenotype. Fifteen of the 28 had the methyl group at C-14 of the sterol nucleus and these represented 96% of the total sterol mass in the specimen (excluding cholesterol). These results strongly suggest that sterol 14alpha-demethylase was blocked in these organisms. Twenty-four of the 28 were 24-alkylsterols, indicating that methylation of the C-24 position of the sterol side chain by S-adenosyl-L-methionine:sterol C-24 methyl transferase was fully functional.
Insights
Pneumocystis jirovecii, a fungus causing lung infections, synthesizes unique sterols. This study reveals a blockage in sterol 14alpha-demethylase, impacting fungal sterol synthesis and potentially explaining treatment resistance.
Area of Science:
- Fungal biochemistry
- Medical mycology
- Molecular biology
Background:
- Antifungal drugs targeting sterol synthesis are common but ineffective against Pneumocystis jirovecii.
- P. jirovecii synthesizes unique C28 and C29 24-alkylsterols, lacking ergosterol.
- Two distinct sterol phenotypes exist in P. jirovecii.
Purpose of the Study:
- To elucidate the sterol composition of P. jirovecii from a human lung specimen.
- To investigate the functional status of key enzymes in P. jirovecii sterol biosynthesis.
Main Methods:
- Nuclear magnetic resonance (NMR) analysis of sterols.
- Characterization of sterol molecular species from a human lung P. jirovecii specimen.
Main Results:
- 28 sterol molecular species were identified, with 15 having a methyl group at C-14 (96% of total sterol mass).
- This indicates a blockage in sterol 14alpha-demethylase activity.
- 24 of the 28 sterols were 24-alkylated, showing functional S-adenosyl-L-methionine:sterol C-24 methyl transferase.
Conclusions:
- The findings suggest a sterol 14alpha-demethylase block in this P. jirovecii phenotype.
- The C-24 methyltransferase activity remains functional.
- Understanding these sterol pathways may inform new therapeutic strategies against P. jirovecii infections.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Atypical Pneumonia
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema

